LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF 10A	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	513	9337	10401	0.8977	0.8924
MCF 10A	AZD8055	0.04	uM	LJP6	2	A12	72	hr	513	1890	10401	0.1817	0.1392
MCF 10A	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	513	1244	10401	0.1196	0.0739
MCF 10A	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	513	9350	10401	0.8989	0.8937
MCF 10A	AZD7762	0.04	uM	LJP6	1	L06	72	hr	513	7567	10401	0.7275	0.7134
MCF 10A	AZD8055	0.04	uM	LJP6	1	A12	72	hr	513	2495	10401	0.2399	0.2004
MCF 10A	Afatinib	0.04	uM	LJP6	3	G24	72	hr	513	380	10401	0.0365	-0.0135
MCF 10A	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	513	10099	10401	0.9710	0.9694
MCF 10A	AT-7519	0.04	uM	LJP6	1	K06	72	hr	513	9715	10401	0.9340	0.9306
MCF 10A	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	513	9647	10401	0.9275	0.9237
MCF 10A	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	513	10132	10401	0.9741	0.9728
MCF 10A	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	513	9800	10401	0.9422	0.9392
MCF 10A	AZD7762	0.04	uM	LJP6	2	L06	72	hr	513	6915	10401	0.6648	0.6474
MCF 10A	AZD7762	0.04	uM	LJP6	3	L06	72	hr	513	6118	10401	0.5882	0.5668
MCF 10A	Afatinib	0.04	uM	LJP6	1	G24	72	hr	513	381	10401	0.0366	-0.0134
MCF 10A	Afatinib	0.04	uM	LJP6	2	G24	72	hr	513	293	10401	0.0282	-0.0223
MCF 10A	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	513	9943	10401	0.9560	0.9537
MCF 10A	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	513	9914	10401	0.9532	0.9507
MCF 10A	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	513	1249	10401	0.1201	0.0744
MCF 10A	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	513	1141	10401	0.1097	0.0635
MCF 10A	AT-7519	0.04	uM	LJP6	2	K06	72	hr	513	10001	10401	0.9615	0.9595
MCF 10A	AT-7519	0.04	uM	LJP6	3	K06	72	hr	513	10020	10401	0.9634	0.9615
MCF 10A	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	513	9287	10401	0.8929	0.8873
MCF 10A	AZD8330	0.04	uM	LJP5	1	G24	72	hr	513	367	10401	0.0353	-0.0148
MCF 10A	AZD8055	0.04	uM	LJP6	3	A12	72	hr	513	3125	10401	0.3005	0.2641

<
<<
Previous
Page 1 of 497
Next
>>
>
1 to 25 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)